Sevoflurane is named as an intervention in 4 current clinical trials in our China and India registers. 3 are recruiting patients now. The most common phase is Observational. The sponsor with the most trials is Sir Ganga Ram Hospital (1). The most-studied condition is Postoperative Delirium. The EU clinical trials register (CTIS) separately lists 1 authorised or ongoing trial.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Total Intravenous Anesthesia and Recurrence Free Survival
NCT04513808 · ClinicalTrials.gov ↗ · Esophageal Cancer
|
Phase 3 | Recruiting | The Cleveland Clinic | China |
|
Incidence of Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery
NCT04707794 · ClinicalTrials.gov ↗ · Postoperative Delirium
|
Observational | Recruiting | Sir Ganga Ram Hospital | India |
|
General Anesthetics-related Changes in Prefrontal EEG During Pediatric Surgical Anesthesia
NCT05210764 · ClinicalTrials.gov ↗ · General Anesthetic, Electroencephalogram
|
Observational | Recruiting | Peking University First Hospital | China |
|
Ciprofol, Propofol and Sevoflurane for Postoperative Delirium in Elderly Brain Tumor Patients
NCT07799623 · ClinicalTrials.gov ↗ · Brain Neoplasms, Delirium - Postoperative
|
Not applicable | Not yet open | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Authorised or ongoing trials in the EU Clinical Trials Information System that list a product containing Sevoflurane. Many trials are registered in both CTIS and ClinicalTrials.gov, so these are shown separately rather than added to the count above. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
|
A single centre parallel-group randomized control trial of Magnetic Resonance Assessment of Variations in Effects of anaesthesia on renaL perfusion in children
2025-520627-25-00 · CTIS ↗ · Physiological processes
|
Phase 4 | Authorised | Region Uppsala | Sweden |
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
3 single-substance products containing Sevoflurane on the HPRA medicines list.
No entry for Sevoflurane in the EMA, FDA or German BfArM shortage lists we track.
| Lead sponsor | Trials |
|---|---|
| Sir Ganga Ram Hospital | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| Peking University First Hospital | 1 |
| The Cleveland Clinic | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 3 | 2 |
| Clinical trials in India | 1 | 1 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers. CTIS does not publish a recruiting flag; its trials may also appear in the registers above.
4 current trials in our China and India registers name Sevoflurane as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 4 trials are recruiting: 2 with sites in China and 1 with sites in India. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Sir Ganga Ram Hospital (1), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1), Peking University First Hospital (1) and The Cleveland Clinic (1). The number in brackets is how many trials each organisation leads.
Yes. The HPRA medicines list includes 3 single-substance products containing Sevoflurane, for example Sevoflurane 100% Inhalation Vapour, liquid (Piramal Critical Care B.V.). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
Not in the lists we track: Sevoflurane has no entry in the EMA, FDA or German BfArM shortage registers as of their latest sync.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Sevoflurane works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Sevoflurane works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Sevoflurane (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.